041910 — Polaris AI Pharma Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual income statement for Polaris AI Pharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	61,324	60,401	62,036	64,215	59,602
Cost of Revenue
Gross Profit	17,370	13,826	12,665	14,297	11,274
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	54,323	56,195	58,875	58,871	59,368
Operating Profit	7,000	4,205	3,162	5,344	235
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	19,391	7,773	-8,415	4,475	4,208
Provision for Income Taxes
Net Income After Taxes	15,733	6,875	-6,364	3,824	3,948
Net Income Before Extraordinary Items
Net Income	15,733	6,875	-6,364	3,824	3,948
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	15,733	6,875	-6,364	3,824	3,948
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,417	585	-545	327	316
Dividends per Share